Impax to pay $35 million to settle part of Solodyn antitrust litigation

BOSTON (Reuters) - Impax Laboratories Inc has agreed to pay $35 million to resolve part of litigation over claims it entered into an anticompetitive deal in a patent case to delay releasing a generic version of the acne medication Solodyn.

from Reuters: U.S. http://ift.tt/2FyfvsD